Merck & Co., Inc. (MRK) vs Space Exploration Technologies Corp. Class A Common Stock (SPCX)

Merck & Co., Inc. develops pharmaceutical products across multiple therapeutic areas, including cardiometabolic disorders, oncology, and infectious diseases. In cancer treatment, its immuno-oncology portfolio, led by Keytruda, represents a significant driver of total revenue. The company also maintains a strong vaccines business focused on preventing pediatric illnesses, alongside Gardasil for human papillomavirus. In addition, Merck markets animal health products. Geographically, 47% of the company’s sales come from its U.S. human health segment, which includes pharmaceuticals and vaccines.

Space Exploration Technologies Corp., known as SpaceX, is an aerospace and satellite communications company founded by Elon Musk. The company designs, manufactures and launches reusable rockets and spacecraft, including the Falcon launch family, Dragon spacecraft and the Starship system under development. SpaceX also operates Starlink, a low Earth orbit satellite broadband network serving consumers, businesses, governments and mobility markets. Its business model combines launch services, satellite internet, defense and civil space contracts, and longer-term ambitions around fully reusable heavy-lift space transportation.